MedTrace Logo

Histological Evaluation of BTL-785F Device's Effect on Submental Subcutaneous Adipose Tissue

NCT06282172 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2025-02-07

No results posted yet for this study

Summary

This study aims to evaluate the safety and effectiveness of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive reduction of subcutaneous submental fat.

Conditions

  • Fat Burn

Interventions

DEVICE

Treatment with BTL-785-7

Treatment with BTL-785-7 delivering simultaneously radiofrequency (RF) and HIFES energy on the submental area

Sponsors & Collaborators

  • BTL Industries Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-25
Primary Completion
2023-10-31
Completion
2023-12-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06282172 on ClinicalTrials.gov